Literature DB >> 18679381

From randomized trials to registry studies: translating data into clinical information.

Morgan L Brown1, Bernard J Gersh, David R Holmes, Kent R Bailey, Thoralf M Sundt.   

Abstract

All clinicians face the challenge of practicing evidence-based medicine and are confronted with data from a variety of studies, ranging from prospective randomized and registry studies to retrospective analyses. Unfortunately, the data frequently provide conflicting recommendations. How then should one interpret the information so that study findings can be applied directly in patient care? To evaluate the relevance of the abundance of studies published and how they apply to an individual patient, physicians must understand subtle nuances of study design and their effect on the interpretation of the results. In this Review, we examine the strengths and weaknesses of different study designs with the aim of providing the reader with a greater understanding how best to apply study results in the clinical setting.

Entities:  

Mesh:

Year:  2008        PMID: 18679381     DOI: 10.1038/ncpcardio1307

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  9 in total

1.  An ethical hierarchy for decision making during medical emergencies.

Authors:  Patrick D Lyden; Brett C Meyer; Thomas M Hemmen; Karen S Rapp
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

2.  Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.

Authors:  Charles B Simone; Kevin Kramer; William P O'Meara; Justin E Bekelman; Arnaud Belard; James McDonough; John O'Connell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-13       Impact factor: 7.038

3.  Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer.

Authors:  Charles B Simone; David Ly; Tu D Dan; John Ondos; Holly Ning; Arnaud Belard; John O'Connell; Robert W Miller; Nicole L Simone
Journal:  Radiother Oncol       Date:  2011-06-12       Impact factor: 6.280

Review 4.  Clinical experience with insulin glargine in type 1 diabetes.

Authors:  Satish Garg; Emily Moser; Marie-Paule Dain; Anastasia Rodionova
Journal:  Diabetes Technol Ther       Date:  2010-10-22       Impact factor: 6.118

Review 5.  Chronic coronary artery disease: diagnosis and management.

Authors:  Andrew Cassar; David R Holmes; Charanjit S Rihal; Bernard J Gersh
Journal:  Mayo Clin Proc       Date:  2009-12       Impact factor: 7.616

6.  Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery.

Authors:  Alexander G G Turpie; André C Schmidt; Reinhold Kreutz; Michael R Lassen; Waheed Jamal; Lorenzo Mantovani; Sylvia Haas
Journal:  Vasc Health Risk Manag       Date:  2012-06-01

7.  Determining the prevalence and predictors of sleep disordered breathing in patients with chronic heart failure: rationale and design of the SCHLA-HF registry.

Authors:  Holger Woehrle; Olaf Oldenburg; Michael Arzt; Andrea Graml; Erland Erdmann; Helmut Teschler; Karl Wegscheider
Journal:  BMC Cardiovasc Disord       Date:  2014-04-09       Impact factor: 2.298

8.  Hot topics and trends in cardiovascular research.

Authors:  Diane Gal; Bart Thijs; Wolfgang Glänzel; Karin R Sipido
Journal:  Eur Heart J       Date:  2019-07-21       Impact factor: 29.983

Review 9.  Lupus Cohorts.

Authors:  Christopher Redmond; Omer Pamuk; Sarfaraz A Hasni
Journal:  Rheum Dis Clin North Am       Date:  2021-06-10       Impact factor: 2.032

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.